These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12640302

  • 1. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG, Ringers J, Sick EA, Ramdien-Murli S, Kuhn EM, Boon L, Jonker M.
    Transplantation; 2003 Mar 15; 75(5):637-43. PubMed ID: 12640302
    [Abstract] [Full Text] [Related]

  • 2. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP, Ossevoort M, Sick EA, Haanstra K, Jonker M.
    Transpl Immunol; 2003 Mar 15; 11(2):215-22. PubMed ID: 12799206
    [Abstract] [Full Text] [Related]

  • 3. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG, Sick EA, Ringers J, Wubben JA, Kuhn EM, 't Hart BA, Boon L, Jonker M.
    Transplantation; 2006 Nov 15; 82(9):1194-201. PubMed ID: 17102771
    [Abstract] [Full Text] [Related]

  • 4. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA, Ringers J, Kuhn EM, Boon L, Lorré K, van den Hout Y, Bruijn JA, de Boer M, Jonker M, de Waele P.
    Transplantation; 1999 Oct 15; 68(7):1010-8. PubMed ID: 10532543
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
    Haegel-Kronenberger H, Haanstra K, Ziller-Remy C, Ortiz Buijsse AP, Vermeiren J, Stoeckel F, Van Gool SW, Ceuppens JL, Mehtali M, De Boer M, Jonker M, Boon L.
    Gene Ther; 2004 Feb 15; 11(3):241-52. PubMed ID: 14737083
    [Abstract] [Full Text] [Related]

  • 6. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
    Bîrsan T, Hausen B, Higgins JP, Hubble RW, Klupp J, Stalder M, Celniker A, Friedrich S, O'Hara RM, Morris RE.
    Transplantation; 2003 Jun 27; 75(12):2106-13. PubMed ID: 12829920
    [Abstract] [Full Text] [Related]

  • 7. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons.
    Boulday G, Ashton-Chess J, Bernard P, Karam G, Vié H, Moreau A, Minault D, Lorré K, Soulillou JP, Blancho G.
    Nephrol Dial Transplant; 2004 Jul 27; 19(7):1752-60. PubMed ID: 15069178
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F, Hori J, Kamiya K, Kaji Y, Oshika T, Amano S, Yamagami S, Tsuru T, Tanaka S, Matsuda H, Yagita H, Okumura K.
    Exp Eye Res; 2002 Jan 27; 74(1):131-9. PubMed ID: 11878826
    [Abstract] [Full Text] [Related]

  • 9. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A, Suzuki T, Sugitani A, Itoh T, Ueki S, Aoyagi T, Yamashita K, Taniguchi M, Takahashi N, Miura T, Shimamura T, Furukawa H, Todo S.
    Transplantation; 2007 Oct 27; 84(8):1020-8. PubMed ID: 17989608
    [Abstract] [Full Text] [Related]

  • 10. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
    Tsai MK, Ho HN, Chien HF, Ou-Yang P, Lee CJ, Lee PH.
    Transplantation; 2004 Jan 15; 77(1):48-54. PubMed ID: 14724434
    [Abstract] [Full Text] [Related]

  • 11. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
    Wang Z, Morelli AE, Hackstein H, Kaneko K, Thomson AW.
    Transplantation; 2003 Aug 15; 76(3):562-71. PubMed ID: 12923445
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H, Lu HM, Hu WM, Tian BL, Liu XB, Zhang ZD, Mai G.
    Transplant Proc; 2007 Dec 15; 39(10):3452-4. PubMed ID: 18089405
    [Abstract] [Full Text] [Related]

  • 13. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP, Xu H, Tadaki DK, Celniker A, Burkly LC, Berning JD, Cruzata F, Elster EA, Gray G, Kampen RL, Swanson SJ, Harlan DM, Kirk AD.
    Transplantation; 2002 Nov 27; 74(10):1365-9. PubMed ID: 12451232
    [Abstract] [Full Text] [Related]

  • 14. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.
    Diabetes; 2006 Jan 27; 55(1):27-33. PubMed ID: 16380473
    [Abstract] [Full Text] [Related]

  • 15. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
    Kirk AD, Tadaki DK, Celniker A, Batty DS, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM.
    Transplantation; 2001 Aug 15; 72(3):377-84. PubMed ID: 11502964
    [Abstract] [Full Text] [Related]

  • 16. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
    Spriewald BM, Ensminger SM, Bushell A, Wood KJ.
    Transplantation; 2008 Dec 15; 86(11):1615-21. PubMed ID: 19077898
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.
    Transplantation; 2005 Aug 27; 80(4):546-54. PubMed ID: 16220623
    [Abstract] [Full Text] [Related]

  • 18. Costimulation blockade followed by a 12-week period of cyclosporine A facilitates prolonged drug-free survival of rhesus monkey kidney allografts.
    Haanstra KG, Sick EA, Ringers J, Wubben JA, Kuhn EM, Boon L, Jonker M.
    Transplantation; 2005 Jun 15; 79(11):1623-6. PubMed ID: 15940054
    [Abstract] [Full Text] [Related]

  • 19. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
    Ziller C, Stoeckel F, Boon L, Haegel-Kronenberger H.
    Gene Ther; 2002 May 15; 9(9):537-46. PubMed ID: 11973629
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.